Quantitative Po₂ Imaging in Vivo with Perfluorocarbon F-19 NMR: Tracking Oxygen from the Airway Through the Blood to Organ Tissues

References

• Thomas S. R. The Biomedical Applications of Fluorine-19 NMR. Magnetic Resonance Imaging. Second Edition: Volume II: Physical Principles and Instrumentation, C. L. Partain, R. R. Price, J. A. Patton. W.B. Saunders, Philadelphia, Pennsylvania 1988; 1536–1552
   Google Scholar
• Clark L. C., Jr., Ackerman J. L., Thomas S. R., Millard R. W. High Contrast Tissue and Blood Oxygen Imaging Based on Fluorocarbon 19-F NMR Relaxation Times. The Society of Magnetic Resonance in Medicine, Second Annual Meeting, San Francisco, California, 1983, 95–96, (Abstract book)
   Google Scholar
• Mason R. P. Non-Invasive Physiology: 19F NMR of Perfluorocarbons. Biomaterials, Artificial Cells, and Immobilization Biotechnology 1993, this volume
   Google Scholar
• Thomas S. R., Clark L. C., Jr., Ackerman J. L. MR Imaging of the Lung Using Liquid Perfluorocarbons. J. of Computer Assisted Tomography 1986; 10(1)1–9
   PubMedGoogle Scholar
• Fishman J. E., Joseph P. M., Floyd T. F. Oxygen-Sensitive F-19 NMR Imaging of the Vascular System In Vivo. Magnetic Resonance Imaging 1987; 5: 279–285
   PubMedGoogle Scholar
• Mason R. P., Jeffrey F. M., Malloy C. R. A Non-Invasive Assessment of Myocardial Oxygen Tension: 19F NMR Spectroscopy of Sequestered Perfluorocarbon Emulsion. Magnetic Resonance in Medicine 1992; 27: 310–317
   PubMed Web of Science ®Google Scholar
• Wilson C. A., Berkowitz B. A., McCuen B. W., II. Measurement of Preretinal Oxygen Tension in Vitrectomized Human Eye Using Fluorine-19 Magnetic Resonance Spectroscopy. Arch. Opthal 1992; 110: 1098–1100
   PubMedGoogle Scholar
• Thomas S. R., Millard R. W., Pratt R. G. Partial Pressure of Oxygen (pO2) Imaging Using F-19 NMR of Perfluorocarbon Blood Substitute Emulsions in the Porcine Model. Society of Magnetic Resonance in Medicine, Ninth Annual Meeting, New York, NY, 1990, 573, (Abstract book)
   Google Scholar
• Busse L. J., Thomas S. R., Pratt R. G. Deconvolution Techniques for Removing the Effects of Chemical Shift in 19F Nuclear Magnetic Resonance Imaging of Perfluorocarbon Compounds. Medical Physics 1986; 13(4)518–524
   PubMedGoogle Scholar
• Busse L. J., Pratt R. G., Thomas S. R. Deconvolution of Chemical Shift Spectra in Two- or Three-Dimensional [19F] MR Imaging. J. of Computer Assisted Tomography 1988; 12(5)824–835
   PubMedGoogle Scholar
• Parhami P., Fung B. M. Fluorine-19 Relaxation Study of Perfluoro Chemicals as Oxygen Carriers. J. Phys. Chem 1983; 87: 1928–1931
   Web of Science ®Google Scholar
• Lai C. S., Stair S. J., Miziorko H. Effect of Oxygen and the Lipid Spin Label TEMPO-Laurate on Fluorine-19 and Proton Relaxation Rates of the Perfluorochemical Blood Substitute, FC-43 Emulsion. J. of Magnetic Resonance 1984; 57: 447–452
   Google Scholar
• Pykett I. L., Rosen B. R., Buonanna F. S. Measurement of Spin-Lattice Relaxation Times in Nuclear Magnetic Resonance Imaging. Phys. Med. Biol 1983; 28: 723–729
   PubMedGoogle Scholar
• Thomas S. R., Pratt R. G., Shiferaw Y., Millard R. W. Evaluation of a T1 Imaging Sequence for the In Vivo Imaging of pO2 Using Perfluorocarbon (PFC) F-19 NMR. Society of Magnetic Resonance in Medicine, Eleventh Annual Meeting, BerlinGermany, 1992, 4311, (Abstract book)
   Google Scholar
• Pratt R. G., Shiferaw Y., Thomas S. R. Utilization of a Gradient Echo F-19 3D-Volume Acquisition Imaging Protocol for Quantitation of pO2 in Perfluorinated Blood Substitutes. Radiological Society of North America 78th Scientific Assembly and Annual Meeting, Chicago, IL, 1992
   Google Scholar
• Thomas S. R., Pratt R. G., Millard R. W. Evaluation of the Influence of the Aqueous-Phase Bioconstituent Environment on the F-19 Tl of Perfluorocarbon Blood Substitute Emulsions. Radiological Society of North America 77th Scientific Assembly and Annual Meeting, Chicago, IL, 1991, 159, (Abstract book) Manuscript submitted for publication (1993)
   Google Scholar
• Alpha Therapeutic Corporation, 5555 Valley Blvd., Los Angeles, CA 92121 (Distributor) and Green Cross Corporation, Osaka, 932–1201 ⅓, Camon-Cho, Joto-ku, Japan (Manufacturer)
   Google Scholar
• Alliance Pharmaceutical Corp., 3040 Science Park Road, San Diego, CA 92121
   Google Scholar
• Riess J. G., Dalfors J. L., Hanna G. K. Development of Highly Fluid, Concentrated and Stable Fluorocarbon Emulsions for Diagnosis and Therapy. Biomat., Art. Cells and Immob. Biotech 1992; 20: 839–842
   PubMed Web of Science ®Google Scholar
• Clark L. C., Jr., Clark E. W., Moore R. E. Room Temperature-Stable Biocompatible Fluorocarbon Emulsions. Advances in Blood Substitute Research, R. Bolin, R. P. Geyer, G. J. Nemo. Alan R. Liss, New York 1983; 122: 169–180, Progress in Clinical and Biological Research
   Google Scholar
• Burton R. F. Ringer Solutions and Physiological Salines. Chapter XII. Oxygenation and the Use of Dispersed Fluorocarbons. John Wright & Sons, Ltd., Dorchester 1975; 70–72
   Google Scholar
• Thomas S. R., Ackerman J. L., Kereiakes J. G. Practical Aspects Involved in the Design and Set Up of a 0.15T, 6-Coil Resistive Magnet, Whole Body NMR Imaging Facility. Magnetic Resonance Imaging 1984; 2: 341–348
   PubMedGoogle Scholar